The Cruel Irony: How Statins and Metformin Can Affect Nerve Health

There is an uncomfortable irony at the heart of this topic: two of the most widely prescribed medications in the world — statins for cholesterol and metformin for diabetes — can, in some people, quietly deplete the very nutrients that nerves depend on. This does not mean these drugs are villains; they prevent heart attacks, strokes, and the progression of diabetes, and for most people the benefits are substantial. The point of this article is not to frighten anyone off necessary treatment, but to explain a real, manageable interaction so that the nutrients can be monitored and replaced. The answer here is repletion and monitoring, not abandoning needed medication.

Metformin and vitamin B12

Metformin is a cornerstone of diabetes care, and a good one. But a well-documented side effect of long-term use is impaired absorption of vitamin B12. Over years, this can produce a functional or overt B12 deficiency — and because B12 deficiency itself causes peripheral neuropathy, the result can be a patient whose diabetes drug is contributing to the very nerve symptoms being blamed entirely on their diabetes.

This is one of the clearer, better-studied drug–nutrient interactions, and it has a clean solution: periodic monitoring of B12 status in people on long-term metformin, ideally using functional markers like methylmalonic acid and homocysteine rather than serum B12 alone (as discussed in the B12 article), and repletion when needed. Crucially, this is done without stopping metformin — the drug continues to do its job while the B12 is replaced.

Statins and CoQ10

Statins lower cholesterol by inhibiting an enzyme (HMG-CoA reductase) early in the cholesterol synthesis pathway. That same pathway also produces coenzyme Q10 (CoQ10), a molecule essential for mitochondrial energy production. By design, statins can therefore lower CoQ10 levels — and since nerves are metabolically demanding, the theoretical concern is that reduced CoQ10 could affect nerve energy metabolism.

Honesty is important here, because this is a more debated area than the metformin–B12 link. The CoQ10-depletion mechanism is real. Whether statins meaningfully cause peripheral neuropathy has been studied and remains genuinely contested — some observational studies have suggested an association, while others have not confirmed a clear causal link, and any absolute risk appears small. The most defensible position is measured: statin-associated muscle symptoms are well recognized, a neuropathy association is possible but not firmly established, and the benefits of statins for cardiovascular protection are strong and well proven.

The sensible framework: don’t stop — monitor and support

Put together, these interactions call for a specific, non-alarmist approach.

First, do not stop a statin or metformin on your own. Discontinuing a needed cardiovascular or diabetes medication carries real, sometimes serious, risks that typically outweigh the nutrient concerns.

Second, monitor. In people on long-term metformin, check B12 status functionally and periodically. In people on statins with new muscle or nerve symptoms, discuss them with the prescribing clinician.

Third, replete intelligently. Where B12 is low, replace it. Where CoQ10 supplementation is being considered for statin-related symptoms, that is a reasonable, low-risk conversation to have with a physician, recognizing that the evidence for benefit is mixed.

Fourth, look at the whole picture. A person with diabetes on metformin and a statin may have several simultaneous contributors to their neuropathy — the diabetes itself, a metformin-related B12 deficiency, and possibly others. Sorting out how much each contributes is exactly the work of a root-cause evaluation.

Other medications worth knowing about

Metformin and statins are the headliners, but they are not alone. Certain chemotherapy agents are directly neurotoxic and a well-known cause of neuropathy; some antibiotics (including certain fluoroquinolones and long-term use of others) and a handful of other drugs can affect nerves as well. The recurring principle applies: the goal is informed monitoring and, where possible, mitigation — in partnership with the prescriber — rather than reflexive discontinuation.

Frequently asked questions

Key takeaways

• Metformin can impair B12 absorption over time, contributing to neuropathy — a well-documented, manageable interaction.
• Statins can lower CoQ10; a neuropathy link is possible but debated, and any risk appears small.
• The answer is monitoring and repletion, never stopping needed medication on your own.
• Functional B12 testing catches deficiencies a standard test misses in metformin users.
• Multiple contributors often coexist, which is why the full picture matters.

Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754–1761.
2. Infante M, et al. Metformin, vitamin B12 deficiency and peripheral neuropathy (review). Endocrine / review.
3. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy. J Am Coll Cardiol. 2007;49:2231–2237.
4. Emad M, et al. Statins and peripheral neuropathy — evidence and controversy (review).